Perioperative fluid management Surgery Perioperative fluid management
Conditions
Interventions
Sponsors
Eligibility
Inclusion criteria
Inclusion criteria: 1. Patients scheduled for elective laparotomy under general anesthesia 2. Aged between 20 and 55 3. ASA I-II
Exclusion criteria
Exclusion criteria: 1. Urgent surgery patients 2. ASA III-IV 3. Refusal to participate 4. Pregnancy 5. Those undergoing operations under spinal or epidural anaesthesia 6. Blood loss more than 500 ml 7. Acute or chronic kidney disease
Design outcomes
Primary
| Measure | Time frame |
|---|---|
| Brain natriuretic peptide (BNP) levels in plasma and urine after rapid fluid infusion are measured using chemiluminescent microparticle immunoassay (CMIA) at baseline (immediately before anaesthesia), immediately after anaesthesia induction, at 30 minute intervals throughout anaesthesia, and two hours after anaesthesia. | — |
Secondary
| Measure | Time frame |
|---|---|
| 1. Changes in glycocalyx shedding products after rapid fluid loading are measured using ELISA at baseline (immediately before anaesthesia), immediately after anaesthesia induction, at 30 minute intervals throughout anaesthesia, and two hours after anaesthesia 2. Capillary leakage is assessed by measuring plasma albumin levels using IL Test Albumin at baseline (immediately before anaesthesia), immediately after anaesthesia induction at 10 minute intervals, every five minutes for 20 minutes after the end of fluid infusion phase, at 10 minutes intervals until the end of anesthesia and two hours after anaesthesia 3. Fluid kinetics of the infused volume of fluids are measured using Haemoglobin (Hgb) levels detected by Coulter HMX methodology at the same frequency as albumin at baseline (immediately before anaesthesia), immediately after anaesthesia induction at 10 minute intervals, every five minutes for 20 minutes after the end of fluid infusion phase, at 10 minutes intervals until the end of anesthesia and two hours after anaesthesia | — |
Countries
Latvia